ESC Premium Access

Novel prognostic biomarkers identified by proximity extension assay are associated with major bleeding in patients with atrial fibrillation on oral anticoagulation: insights from the ARISTOTLE trial

Presentation

About the speaker

Professor Lars Wallentin

Uppsala Clinical Research Center, Department of Medical Sciences, Uppsala (Sweden)
14 presentations
0 follower

9 more presentations in this session

Different obesity paradox of ischemic stroke without and with atrial fibrillation

Speaker: Associate Professor Y. Baek (Incheon, KR)

Thumbnail

Effectiveness, safety, and composite clinical outcomes between apixaban and other oral anticoagulants for non-valvular atrial fibrillation patients in the US Medicare population

Speaker: Mr A. Dhamane (New York, US)

Thumbnail

Anticoagulation control in octogenarian patients receiving vitamin K antagonists for stroke prevention in atrial fibrillation: the west birmingham AF project

Speaker: Doctor H. Zulkifly (Selangor, MY)

Thumbnail

Temporal trends in antithrombotic patterns for stroke prevention in patients with atrial fibrillation and wide spectrum of coronary artery disease

Speaker: Associate Professor B. Hudzik (Zabrze, PL)

Thumbnail

Dabigatran in real-world asian patients with atrial fibrillation with low body weight: nationwide cohort data covering the entire korean population

Speaker: Doctor D. Kim (Seoul, KR)

Thumbnail

Access the full session

Poster Session 5 - Atrial fibrillation - Stroke prevention 1

Speakers: Professor L. Wallentin, Associate Professor Y. Baek, Mr A. Dhamane, Doctor H. Zulkifly, Associate Professor B. Hudzik...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk